Systematic review of the efficacy of nasal CPAP

Thorax

Volumn 53, Issue 5, 1998, Pages 414-415

  Douglas, Neil J ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COGNITION; DROWSINESS; HUMAN; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; REVIEW; SLEEP APNEA SYNDROME; TREATMENT OUTCOME; WELLBEING;

EID: 0031840026     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.53.5.414     Document Type: Review

References (15)

1. Australian Health Technology Advisory Committee. The effectiveness and cost effectiveness of nasal continuous positive airway pressure in the treatment of obstructive sleep apnoea in adults. Canberra: Government Public Services, 1996.
2. Wright J, Johns R, Watt I, et al. Health effects of obstructive sleep apnoea and effectiveness of continuous positive airway pressure: a systematic review of the research evidence. BMJ 1997;314:851-60.
3. Wright J, Dye R. Systematic review of obstructive sleep apnoea; its effect on health and benefit of treatment. Nuffield Institute for Health, 1995.
4. Sackett DL, Rosenberg WM, Gray J, et al. Evidence based medicine; what it is and what it is not. BMJ 1996;312:71-2.
5. Engleman HM, Martin SE, Deary IJ, et al. Effect of continuous positive airway pressure treatment on daytime function in sleep apnoea/hypopnoea syndrome. Lancet 1994;343:572-5.
6. Kreiger J, Weitzenblum E, Monassier JP, et al. Dangerous hypoxaemia during continuous positive airway pressure treatment of obstructive sleep apnoea. Lancet 1983;ii: 1429-30.
7. Kribbs NB, Pack AI, Kline LR, et al. Effects of one night without nasal CPAP treatment on sleep and sleepiness in patients with obstructive sleep apnea. Am Rev Respir Dis 1993;147:1162-8.
8. Engleman HM, Martin SE, Deary IJ, et al. Effects of CPAP therapy on daytime function in patients with mild sleep apnoea/hypopnoea syndrome. Thorax 1997;52:114-9.
9. Engleman HM, Martin SE, Kingshott RN, et al. Randomised, placebo-controlled trial of daytime function after continuous positive airway pressure (CPAP) therapy for the sleep apnoea/hypopnoea syndrome. Thorax 1998;53:341-5.
10. Hills M, Armitage P. The two period crossover trial. Br J Clin Pharmacol 1979;8:7-20.
11. US Modafinil in Narcolepsy Multicenter Study Group. Modafinil for the treatment of pathological somnolence in narcolepsy. Neurology 1998 (in press).
12. Engleman HM, Deary IJ, Douglas NJ. Daytime function after CPAP and placebo in patients with mild sleep apnea hypopnea syndrome. Am J Respir Crit Care Med 1997;155: A846.
13. Badia JR, Hernandez L, Lyon C, et al. Efficacy of CPAP treatment in moderate to severe sleep apnea hypopnea syndrome. Eur Respir J 1997;10(Suppl 25):310S.
14. Stradling JR, Jenkinson C, Davies RJ, et al. Randomised, sham-placebo controlled, parallel study of nasal continuous positive airway pressure for the treatment of obstructive sleep apnoea: interim analysis. Am J Respir Crit Care Med 1998 (abstract in press).
15. Engleman HM, Jirhandeh-Asgari N, McLeod AL, et al. Self-reported use of CPAP and benefits of CPAP therapy: a patient survey. Chest 1996;109:1470-6.